-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XEN-1101 in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XEN-1101 in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XEN-1101 in Major Depressive Disorder Drug Details: XEN-1101 (1OP-2198) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XEN-1101 in Partial Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XEN-1101 in Partial Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XEN-1101 in Partial Seizure Drug Details: XEN-1101 (1OP-2198) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Metastatic Breast Cancer Drug Details: ST-101 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vafidemstat in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vafidemstat in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vafidemstat in Parkinson's Disease Drug Details: Vafidemstat (ORY-2001) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vafidemstat in Borderline Personality Disorder (BPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vafidemstat in Borderline Personality Disorder (BPD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vafidemstat in Borderline Personality Disorder (BPD) Drug Details: Vafidemstat (ORY-2001)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Sarcomas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Sarcomas Drug Details: ST-101 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Glioblastoma Multiforme (GBM) Drug Details: ST-101 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Gastrointestinal Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Gastrointestinal Tract Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Gastrointestinal Tract Cancer Drug Details: ST-101 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Signet Ring Cell Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Signet Ring Cell Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Signet Ring Cell Squamous Cell Carcinoma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST101 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST101 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST101 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: ST-101 is...